Timing of caffeine ingestion alters postprandial metabolism in rats
2014
Jarrar S.F. | Obeid O.A. | Jarrar, S.F., Department of Nutrition and Food Sciences, Faculty of Agricultural and Food Sciences, American University of Beirut, Beirut, Lebanon | Obeid, O.A., Department of Nutrition and Food Sciences, Faculty of Agricultural and Food Sciences, American University of Beirut, Beirut, Lebanon | Obeid, O.A.; Department of Nutrition and Food Sciences, Faculty of Agricultural and Food Sciences, American University of Beirut, Beirut, Lebanon; email: [email protected] | University: American University of Beirut; Faculty: Faculty of Agricultural and Food Sciences; Department: Nutrition and Food Sciences; | Nutrition and Food Sciences | [email protected] | Faculty of Agricultural and Food Sciences | Jarrar, SF | Obeid, OA | Obeid, OA (reprint author), Amer Univ Beirut, Fac Agr and Food Sci, Dept Nutr and Food Sci, Beirut, Lebanon. | American University of Beirut
Objective: The association between caffeine intake and the risk for chronic diseases, namely type 2diabetes, has not been consistent, and may be influenced by the timing of caffeine ingestion. The aim of this study was to investigate the acute effect of caffeine administered in different scenarios of meal ingestion on postprandial glycemic and lipidemic status, concomitant with changes in body glycogen stores. Methods: Forty overnight-fasted rats were randomly divided into five groups (meal-ingested, caffeine-administered, post-caffeine meal-ingested, co-caffeine meal-ingested, post-meal caffeine-administered), and tube-fed the appropriate intervention, then sacrificed 2 h later. Livers and gastrocnemius muscles were analyzed for glycogen content; blood samples were analyzed for glucose, insulin, triglycerides, and non-esterified fatty acid concentrations. Results: Postprandial plasma glucose concentrations were similar between groups, while significantly higher levels of insulin were witnessed following caffeine administration, irrespective of the timingof meal ingestion. Triglyceride concentrations were significantly lower in the caffeine-administered groups. Regarding glycogen status, although caffeine administration before meal ingestion reduced hepatic glycogen content, co- and post-meal caffeine administration failed toproduce such an effect. Muscle glycogen content was not significantly affected by caffeine administration. Conclusions: Caffeine administration seems to decrease insulin sensitivity as indicated by the sustenance of glucose status despite the presence of high insulin levels. The lower triglyceride levels in the presence of caffeine support the theory of retarded postprandial triglyceride absorption. Caffeine seems to play a biphasic role in glucose metabolism, as indicated by its ability to variably influence hepatic glycogen status. © 2014 Elsevier Inc.
显示更多 [+] 显示较少 [-]Aldughpassi A, 2009, BRIT J NUTR, V101, P1282, DOI 10.1017-S0007114508079610; ASTRUP A, 1990, AM J CLIN NUTR, V51, P759; Battram DS, 2006, J NUTR, V136, P1276; Belza A, 2007, INT J OBESITY, V31, P121, DOI 10.1038-sj.ijo.0803351; Berg JM, 2002, BIOCHEMISTRY-US; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016-S1043-2760(00)00323-4; Bryans JA, 2007, J AM COLL NUTR, V26, P471; Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038-sj.ijo.0801101; EDENS NK, 1990, J LIPID RES, V31, P1423; EMERY PW, 1993, NUTR CANCER, V20, P231; ErcanFang N, 1997, J PHARMACOL EXP THER, V280, P1312; Frayn KN, 2003, BIOCHEM SOC T, V31, P1115; Greenberg JA, 2006, AM J CLIN NUTR, V84, P682; Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337-diabetes.50.10.2349; Hatonen KA, 2012, EUR J NUTR, V51, P801, DOI 10.1007-s00394-011-0258-4; Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001-archinternmed.2009.439; Johnston KL, 2003, AM J CLIN NUTR, V78, P728; Juhel C, 2000, J NUTR BIOCHEM, V11, P45, DOI 10.1016-S0955-2863(99)00070-4; KASHIWAGURA T, 1987, JPN J PHYSIOL, V37, P979, DOI 10.2170-jjphysiol.37.979; Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337-diacare.25.2.364; Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271-bbb.69.2219; Koupenova M, 2013, J CELL PHYS IN PRESS; Konig M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371-journal.pcbi.1002577; Lane JD, 2008, DIABETES CARE, V31, P221, DOI 10.2337-dc07-1112; Lane James D, 2007, Endocr Pract, V13, P239; Larsson SC, 2007, J INTERN MED, V262, P208, DOI 10.1111-j.1365-2796.2007.01840.x; MacKenzie T, 2007, METABOLISM, V56, P1694, DOI 10.1016-j.metabol.2007.07.013; Moisey LL, 2008, AM J CLIN NUTR, V87, P1254; Moisey LL, 2010, BRIT J NUTR, V103, P833, DOI 10.1017-S0007114509992406; Nuttall FQ, 2008, DIABETES-METAB RES, V24, P438, DOI 10.1002-dmrr.863; Obeid OA, 1997, NUTR CANCER, V28, P100; Obeid OA, 2000, INT J OBESITY, V24, P508, DOI 10.1038-sj.ijo.0801189; Obeid OA, 2005, NUTRITION, V21, P224, DOI 10.1016-j.nut.2004.03.026; Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016-j.nut.2012.02.013; Petrie HJ, 2004, AM J CLIN NUTR, V80, P22; Powles JW, 1994, P NUTR SOC, p58A; Qvisth V, 2008, J CLIN ENDOCR METAB, V93, P240, DOI 10.1210-jc.2007-1313; Riserus U, 2008, CURR OPIN CLIN NUTR, V11, P100, DOI 10.1097-MCO.0b013e3282f52708; Robinson LE, 2004, J NUTR, V134, P2528; Rocha Leao MHM, 2003, GLYCOGEN ENCY FOOD S, P2930; Ruesten von A, 2013, EUR J CLIN NUTR, P1; Shearer J, 2003, J NUTR, V133, P3529; Toyoda-Ono Y, 2007, BIOSCI BIOTECH BIOCH, V71, P971, DOI 10.1271-bbb.60635; Tsitsanou KE, 2000, ARCH BIOCHEM BIOPHYS, V384, P245, DOI 10.1006-abbi.2000.2121; Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139-H08-123; VERGAUWEN L, 1994, J CLIN INVEST, V93, P974, DOI 10.1172-JCI117104; Wang S, 2006, J NUTR, V136, P2791; Westerterp-Plantenga M, 2006, PHYSIOL BEHAV, V89, P85, DOI [10.1016-j.physbeh.2006.01.027, 10.1016-j.physbeh.2005.12.014]; Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945-ajcn.111.032573
显示更多 [+] 显示较少 [-]